After four months, however, Wegovy is taken as a 1.7 milligram injection, and finally a 2.4 milligram injection from month five onwards
Image Credit: George Chernilevsky / Wikimedia Commons
GLP-1 is an energy sensor that reduces intestinal motility, prolonging the retention of food in the gut, contributing to more efficient absorption of nutrients and better bioavailability (Winkler et al., 2019)
The regions market is still developing, but improvements in healthcare infrastructure and awareness programs are gradually driving the adoption of more advanced therapies such as GLP-1 receptor agonists and SGLT2 inhibitors
the frequency of specific side effects are dose dependent, with commonly reported side effects including headache, flushing, upset stomach, stuffy nose, urinary tract infection, visual changes such as mild and temporary changes in blue/green colors or increased sensitivity to light, and diarrhea